- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05810012
Comparison of Analgesic Efficacy of PENB Block With FICB in Post Operative Hip Fracture Patients
March 30, 2023 updated by: Moazzam Ali, Pain Medicine Department
Comparison of Analgesic Efficacy of Ultrasound Guided Pericapsular Nerve Group Block Versus Fascia Iliaca Compartment Block in Patients of Hip Fracture
This study was done to evaluate two different interventions for postoperative pain control in patients undergoing hip surgeries.
Fifty patients, divided in two equal groups, were included in the study.
Patients in Group P were given pericapsular nerve group (PENG) block while those in Group F were given fascia iliaca compartment block (FICB).
Pain score, using Numeric Rating scale as a measurement tool, was assessed at one, six, eighteen and twenty fours after the procedure as a primary outcome.
Total tramadol consumption in milligrams was recorded as a secondary outcome.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lahore, Pakistan
- Pain Medicine Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- surgical correction of fracture neck of femur under spinal anaesthesia
Exclusion Criteria:
- allergy to local anaesthetics
- bleeding disorders
- morbid obesity with BMI more than 35
- patients of chronic pain
- drug addiction
- psychiatric issues
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PENG Block Group
|
10ml of 0.125% isobaric bupivacaine injected
|
Experimental: FICB Group
|
20ml of 0.125% isobaric bupivacaine injected
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain score using Numeric Rating scale
Time Frame: 24 hours
|
Pain scored assessed after completion of surgery at one, six, eighteen and twenty fours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Tramadol consumption
Time Frame: 24 hours
|
Total Tramadol consumption In twenty four hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Moazzam Ali, Pain Medicine Department
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2022
Primary Completion (Actual)
October 31, 2022
Study Completion (Actual)
October 31, 2022
Study Registration Dates
First Submitted
March 30, 2023
First Submitted That Met QC Criteria
March 30, 2023
First Posted (Actual)
April 12, 2023
Study Record Updates
Last Update Posted (Actual)
April 12, 2023
Last Update Submitted That Met QC Criteria
March 30, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PENG vs FICB
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fracture Surgery
-
University Health Network, TorontoNot yet recruitingSurgery | Hip-fracture
-
Eurofarma Laboratorios S.A.TerminatedHip Fracture SurgeryBrazil
-
Second Affiliated Hospital of Wenzhou Medical UniversityUnknownAnesthesia | Hip Fracture Surgery | NursingChina
-
Assistance Publique - Hôpitaux de ParisUniversité de Technologie de CompiegneCompletedHip Fracture, Post Surgery Recovery, Muscle ResilienceFrance
-
University Hospital, AngersCompleted
-
Sahlgrenska University Hospital, SwedenCompleted
-
University of AlbertaNot yet recruitingAnesthesia, Local | Surgery | Hip FracturesCanada
-
Ottawa Hospital Research InstituteCompletedSurgery | Hip Fractures | Anesthesia | Gender Bias
-
Karolinska InstitutetStockholm South General HospitalCompletedTrochanteric Hip Fractures | Warfarin Medication | Early SurgerySweden
-
TC Erciyes UniversityCompletedElective Hip Fracture SurgeryTurkey
Clinical Trials on PENG block
-
Mansoura UniversityCompleted
-
Mansoura UniversityCompletedShoulder SurgeryEgypt
-
Diskapi Teaching and Research HospitalCompleted
-
Karaman Training and Research HospitalCompleted
-
Assiut UniversityNot yet recruitingPain, Postoperative
-
Tanta UniversityCompleted
-
Kocaeli Derince Education and Research HospitalMustafa Kemal UniversityUnknownVisual Analogue Score
-
Beni-Suef UniversityRecruiting
-
Ain Shams UniversityRecruiting
-
Ospedale Edoardo BassiniRecruitingComparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THAPost Operative Pain | Regional Anesthesia Morbidity | Arthropathy of Hip | Hip Arthropathy | Anesthesia ComplicationItaly